One of the outpatient treatment alternatives for people in Brookline who are battling with opioid dependence and addiction is opioid maintenance therapy. Some facilities and doctors are certified to administer specific medications to opioid addicted clients, many of which are opioids also and are addiction. With low enough amounts the user does not experience being high and also doesn't have intense cravings and is not experiencing opioid withdrawal. Methadone is the first medication used for this reason, but there are other choices currently to select from.
Methadone is an opiate and can be taken at an out-patient medical center certified to administer the drug, which is taken on a daily basis in liquid or pill form. The cost of the drug is about $150 a month. Buprenorphine is also an opioid based med, and is in pill form often taken one day on, one day off. But different from Methadone which can only be given in highly well-regulated clinics, Buprenorphine can be prescribed and administered in doctor's offices. The monthly cost of buprenorphine is approximately just under $300 per month for the generic version of the medication. There is also a type of buprenorphine that contains naloxone, which is a drug that blocks the effects of opioids. A person consuming this version of the drug, AKA Suboxone, would find it harder to get high from opioids if they relapsed while taking the drug. It is also taken daily, and is priced around $450 /month. Naltrexone is another drug taken in opioid maintenance therapy, but unlike the other medications mentioned it's an opioid blocker and isn't an opioid. There is an option to take this drug as a monthly shot, and that is called Vivitrol. As an opioid blocker, it prevents a person from feeling high from opioids, and therefore lowers the risk associated with relapse. This daily injection costs anywhere from $1000 to $1200 per month.
There are 1 Alcohol and Drug Rehab Programs offering this service in Brookline, MA
For All Drug and Alcohol Treatment Facilities In Brookline, Click Here.